133 related articles for article (PubMed ID: 10445594)
1. Colony-stimulating factor therapy and febrile neutropenia induced by chemotherapy: need for economical studies.
Urban T; Lebeau B
Eur Respir J; 1999 Jun; 13(6):1228-9. PubMed ID: 10445594
[No Abstract] [Full Text] [Related]
2. Chemotherapy-induced neutropenia in lung cancer patients: the role of antibiotic prophylaxis.
Kouranos V; Dimopoulos G; Vassias A; Syrigos KN
Cancer Lett; 2011 Dec; 313(1):9-14. PubMed ID: 21955615
[TBL] [Abstract][Full Text] [Related]
3. [Colony stimulating factors in chemotherapy induced neutropenic fever].
Sanz Rubiales A; García Alvarez G; Centeno Cortés C; Martín Ortega Y; Del Valle Rivero AL; Nieto Sanz J
An Med Interna; 1998 Feb; 15(2):100-4. PubMed ID: 9542208
[TBL] [Abstract][Full Text] [Related]
4. Extensive stage small cell lung cancer: determining suitability for outpatient management of febrile neutropenia.
Rapp JS; Perry MC; Rotche RM
Semin Oncol; 1996 Apr; 23(2):xv-xxii; discussion xxii. PubMed ID: 8623054
[No Abstract] [Full Text] [Related]
5. Role of colony stimulating factors (CSFs) in solid tumours: results of an expert panel.
Gridelli C; Aapro MS; Barni S; Beretta GD; Colucci G; Daniele B; Del Mastro L; Di Maio M; De Petris L; Perrone F; Thatcher N; De Marinis F
Crit Rev Oncol Hematol; 2007 Jul; 63(1):53-64. PubMed ID: 17368037
[TBL] [Abstract][Full Text] [Related]
6. G-CSF for fever and neutropenia induced by chemotherapy.
Hamm JT
N Engl J Med; 1992 Jan; 326(4):269; author reply 270. PubMed ID: 1370180
[No Abstract] [Full Text] [Related]
7. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
Bhana N
Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
[TBL] [Abstract][Full Text] [Related]
8. [Effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with lung cancer].
Ohnoshi T; Ueoka H; Kodani T; Kamei H; Kimura I
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):911-8. PubMed ID: 1693062
[TBL] [Abstract][Full Text] [Related]
9. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
Timmer-Bonte JN; de Boo TM; Smit HJ; Biesma B; Wilschut FA; Cheragwandi SA; Termeer A; Hensing CA; Akkermans J; Adang EM; Bootsma GP; Tjan-Heijnen VC
J Clin Oncol; 2005 Nov; 23(31):7974-84. PubMed ID: 16258098
[TBL] [Abstract][Full Text] [Related]
10. Colony-stimulating factors as an adjunct to chemotherapy in small cell lung cancer.
Urban T; Schuller MP; Lebeau B
Eur Respir J; 1996 Mar; 9(3):596-602. PubMed ID: 8730024
[TBL] [Abstract][Full Text] [Related]
11. [Small cell lung cancer: value of G-CSF].
Trillet V
Pathol Biol (Paris); 1993 Jan; 41(1):46. PubMed ID: 7686284
[No Abstract] [Full Text] [Related]
12. The use of GM-CSF as adjunctive therapy in small cell lung cancer. Presentation of the interim analysis of a large phase II trial.
Pujol JL; Tabah I; Michel FB
Pathol Biol (Paris); 1992 Nov; 39(9):960. PubMed ID: 1311449
[No Abstract] [Full Text] [Related]
13. [Clinical trial of KRN 8601 in patients with neutropenia induced by chemotherapy for lung cancer].
Kimura I; Ohonoshi T; Okabe T; Takaku F; Nishiwaki H; Saijo N; Ikegami H; Fukuoka M; Furuse K
Gan To Kagaku Ryoho; 1990 May; 17(5):999-1003. PubMed ID: 2185694
[TBL] [Abstract][Full Text] [Related]
14. A cost analysis of hematopoietic colony-stimulating factors.
Lyman GH; Balducci L
Oncology (Williston Park); 1995 Nov; 9(11 Suppl):85-91. PubMed ID: 8608061
[TBL] [Abstract][Full Text] [Related]
15. Oral antibiotics for febrile patients with neutropenia due to cancer chemotherapy.
Lishner M
N Engl J Med; 2000 Jan; 342(1):55-6; author reply 56-8. PubMed ID: 10627210
[No Abstract] [Full Text] [Related]
16. Modeling the cost effectiveness of secondary febrile neutropenia prophylaxis during standard-dose chemotherapy.
Timmer-Bonte JN; Adang EM; Termeer E; Severens JL; Tjan-Heijnen VC
J Clin Oncol; 2008 Jan; 26(2):290-6. PubMed ID: 18182670
[TBL] [Abstract][Full Text] [Related]
17. Shifting guidelines for myeloid growth factors: applications in cancer chemotherapy.
Daniel DB; Crawford J;
Curr Hematol Rep; 2005 Nov; 4(6):441-5. PubMed ID: 16232380
[TBL] [Abstract][Full Text] [Related]
18. G-CSF reduces incidence of chemotherapy-associated infections.
Oncology (Williston Park); 1990 Aug; 4(8):12. PubMed ID: 1698430
[No Abstract] [Full Text] [Related]
19. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.
Crawford J; Ozer H; Stoller R; Johnson D; Lyman G; Tabbara I; Kris M; Grous J; Picozzi V; Rausch G
N Engl J Med; 1991 Jul; 325(3):164-70. PubMed ID: 1711156
[TBL] [Abstract][Full Text] [Related]
20. Colony-stimulating factor use and impact on febrile neutropenia among patients with newly diagnosed breast, colorectal, or non-small cell lung cancer who were receiving chemotherapy.
McCune JS; Sullivan SD; Blough DK; Clarke L; McDermott C; Malin J; Ramsey S
Pharmacotherapy; 2012 Jan; 32(1):7-19. PubMed ID: 22392824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
